Titlebook: Supportive Care in Cancer Patients II; Hans-Jörg Senn,Agnes Glaus Conference proceedings 1991 Springer-Verlag Berlin Heidelberg 1991 cance

SSRIS

Cytokines and Hematopoietins: Physiology, Pathophysiology, and Potential as Therapeutic Agents-intensity regimens, with the potential of achieving higher cure rates in some patient groups. In this chapter we will focus on insights gained into the in vivo physiology of human cytokines and on the experience gained so far with the use of cytokines in cancer therapy.

arousal

Recombinant Human Interleukin-3 in Patients with Hematopoietic Failurete-macrophage CSF (GM-CSF) and granulocyte CSF (G-CSF), can indeed elevate total leukocyte counts in patients with bone marrow failure [1–14]. However, improvements in erythropoiesis and thrombopoiesis were observed only sporadically [2, 6, 7, 8].

现代

Treatment of Severe Cancer Pain by Continuous Infusion of Subcutaneous Opioids a three-step treatment as proposed by the World Health Organisation are widely accepted [2]. With this therapeutic strategy, using the WHO analgesic ladder, cancer pain relief can be achieved in a majority of patients [3].

脾气暴躁的人

Controlling Emesis in Patients Receiving Cancer Chemotherapye emetic problems were identified, an enhanced understanding of the physiology of emesis came about, effective agents were found, useful doses and schedules for these agents were established, combination regimens of greater efficacy were tested, and the ability to effectively prevent emesis was markedly improved.

Popcorn

Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor for the Intensification of Cytostlls to form mature colonies of granulocytes and/or macrophages [1–3]. Clinically, GM-CSF may have a role in stimulating myelopoietic regeneration after irradiation, treatment with cytostatic drugs, bone marrow transplantation and other treatments.

oblique

Recent Results in Cancer Researchhttp://image.papertrans.cn/t/image/882177.jpg

溃烂

https://doi.org/10.1007/978-3-642-84138-5cancer; cancer research; cancer therapy; care; chemotherapy; endoscopy; leukemia; liver; lung cancer; oncolog

亲属

诱拐

Ejaculate

5-Hydroxytryptamine-3 Antagonists: A New Class of Potent Antiemetics in Cancer TherapyFor many years nausea and vomiting have been recognized as side-effects of numerous chemotherapeutic regimens. The development of the useful new agent cisplatin, due with its powerful emetic effect, highlighted this patient problem.